Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 810-817-1 | CAS number: 1473386-29-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Gastro intestinal-, respiratory- and dermal absorption to a major extent are not expected due to physico-chemical properties and in vitro dermal absorption study of the structural analogue dodecyl methacrylate. Dodecyl methacrylate appears to be absorbed through rat skin and epidermis to a low extent, 0.26 % in 24 hrs. It is fully metabolized to methacrylic acid during the passage (first-pass effect). As indicated by a PB-PK model used in this study, human skin is 14 times less permeable to dodecyl methacrylate than rat skin.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Physical chemical properties
The test substance is a liquid UVCB containing isomers with a molecular weight of 324.54 g/mol. The calculated log Pow value is 9.1 at 25 °C and the solubility in water is < 24 µg/L at 20 °C. No data on hydrolysis and surface tension are available since the substance is poorly soluble. The vapour pressure of the substance is 0.0000109 hPa at 20 °C. These physico-chemical properties of the substance will enable qualitative judgements of the toxicokinetic behaviour (Guidance on information requirements and chemical safety assessment Chapter R.7.c, R.7.12 Guidance on Toxicokinetics).
GI absorption
No experimental data are available for GI absorption. Substances with a molecular weight below 500, high water solubility and a log Pow between -1 and 4 are favourable for absorption. With a log Pow > 4 passive diffusion through membranes is not expected but the substance may form micelles and be absorbed into the lymphatic system. However, due to the very poor water solubility of < 1 mg/L, only very low concentrations of the substance are bioavailable. In addition, no signs of systemic toxicity indicating that absorption has occurred were seen in an acute oral toxicity test up to 2000 mg/kg bw. Furthermore an oral repeated dose study is available for the structural analogue N-Dodecyl methacrylate (CAS 142-90-5) and no treatment related effects were observed in this study which could indicate that the substance may be absorbed.
Respiratory absorption – Inhalation
No experimental data are available for respiratory absorption. The vapour pressure of C 17 Methacrylate is only 0.0000109 hPa and therefore inhalation is not a relevant route of absorption.
Dermal absorption
C 17 Methacrylate is a liquid with a molecular weight below 500 g/mol which would favour dermal uptake, but with a very low water solubility <1 µg/l dermal uptake from the stratum corneum into the epidermis is likely to be very low. With log Pow > 6 the rate of transfer between the stratum corneum and the epidermis will be slow and will limit absorption across the skin. Uptake into the stratum corneum itself is expected to be slow.
In addition, no signs of systemic toxicity indicating absorption were observed in an acute dermal toxicity study on C17 Methacrylate with doses up to 5000 mg/kg bw.
For the structural analogue dodecyl methacrylate the dermal absorption (steady-state flux) has been estimated by calculation using the principles defined in the Potts and Guy prediction model (Heylings JR, 2013) (Table 1). Based on a molecular weight of 254.41 g/mol and a Kow of 6.68, the predicted flux of dodecyl methacrylate is 0.003 μg/cm²/h; thus, the relative dermal absorption is minimal. In addition, in an in vitro skin absorption study Lauryl methacrylate (70 % Dodecyl methacrylate and 25 % tetradecyl methacrylate) was applied to skin of male Wistar rats. The 24 hour absorption was determined to be 0.264%. In conclusion, absorption of dodecyl methacrylate via the skin will be limited and subsequently it can be concluded that dermal absorption of C 17 Methacrylate is likely to be minimal.
Table 1: Terms used for categorising absorption of chemicals through human skin:
Kp (cm/h)
|
Absorption Rate (µg/cm²/h)
|
Relative Absorption Rate Category
|
Predicted Absorption from Normal Exposure |
1E-02 – 1E-01 |
>500 |
Very fast |
Very high |
1E-03 – 1E-02 |
100-500 |
Rapid - Fast |
High |
1E-04 – 1E-03 |
10-50 50-100 |
Slow - Moderate Moderate - Rapid |
Moderate |
1E-05 – 1E-04 |
0.1-10 |
Very slow - Slow |
Low |
1E-06 – 1E-05 |
0.001-0.1 |
Extremely - Very slow |
Minimal |
<1E-06 |
<0.001 |
Extremely slow |
Negligible |
Metabolism
No data are available on the metabolism of C 17 Methacrylate in vivo.
The prominent pathway for the metabolism of higher methacrylate esters starts with ester hydrolysis resulting in methacrylic acid and the corresponding alcohol (Jones, 2002); (McCarthy and Witz, 1997). While the acid is further metabolised via the valine pathway of the citric acid cycle (ECETOC, 1995; European Union, 2002) the alcohol may be further metabolised by the two standard metabolic pathways for fatty alcohols (1. oxidation: fatty alcohol -> aldehyde -> acid, and subsequently CoA-mediated fatty acid metabolism - or - 2.: glucuronidation of the alcohol and excretion). Alkyl esters of methacrylic acid up to C8 (2-ethylhexyl methacrylate) showed rapid metabolism with half lives in rat blood of less than 30 min (Jones, 2002):
A series of in vitro and in vivo studies with a series of methacrylates were used to develop a PBPK model that accurately predicts the metabolism and fate of these monomers. The studies confirmed that alkyl methacrylate esters are rapidly hydrolysed in the organism by ubiquitous carboxylesterases. First pass (local) hydrolysis of the parent esters has been shown to be significant for all routes of exposure. In vivo measurements of rat liver indicated this organ as with the greatest esterase activity. Similar measurements for skin microsomes indicated an approximately 20-fold lower activity than for liver. Nevertheless, this activity was substantial and capable of almost complete first-pass metabolism of the alkyl methacrylates applied on skin. For example, no parent ester penetrated whole rat skin in vitro for n-butyl methacrylate, octyl methacrylate or lauryl methacrylate. When tested experimentally, only methacrylic acid was identified in the receiving fluid. In addition, model predictions indicate that esters of ethyl methacrylate or larger would be completely hydrolysed before entering the circulation via skin absorption. This pattern is consistent with a lower rate of absorption for these esters indicating that the rate of metabolism is within the metabolic capacity of the skin. Parent ester also was hydrolyzed by S9 fractions from nasal epithelium and was predicted to be effectively hydrolysed following inhalation exposure.
These studies showed that any systematically absorbed parent ester will be effectively removed during the first pass through the liver (CL as % LBF, see table). In addition, removal of methacrylic acid from the blood also occurs rapidly (T50 %; see table 2).
Table 2: Rate constants for the ester hydrolysis by rat-liver microsomes and predicted systemic fate kinetics from methacrylates following i.v. administration:
Ester |
Vmax |
Km |
CL (%LBF) |
T50%(min) |
Cmax(MAA) (mg L-1) |
Tmax(MAA) (min) |
MAA |
- |
- |
51.6% |
- |
- |
- |
MMA |
445.8 |
164.3 |
98.8% |
4.4 |
14.7 |
1.7 |
EMA |
699.2 |
106.2 |
99.5% |
4.5 |
12.0 |
1.8 |
i-BMA |
832.9 |
127.4 |
99.5% |
11.6 |
7.4 |
1.6 |
n-BMA |
875.7 |
77.3 |
99.7% |
7.8 |
7.9 |
1.8 |
HMA |
376.4 |
34.4 |
99.7% |
18.5 |
5.9 |
1.2 |
2EHMA |
393.0 |
17.7 |
99.9% |
23.8 |
5.0 |
1.2 |
OMA |
224.8 |
11.0 |
99.9% |
27.2 |
5.0 |
1.2 |
MAA = Methacrylic acid (CAS 79-41-4); MMA = Methyl methacrylate (CAS 80-62-6); EMA = Ethyl methacrylate (CAS 97-63-5); i-BMA = Isobutyl methacrylate (CAS 97-86-9); n-BMA = n-Butyl methacrylate (CAS 97-88-1); HMA = Hexyl methacrylate (CAS 142-09-6); 2EHMA = 2-Ethylhexyl methacrylate (CAS 688-84-6); OMA = Octyl methacrylate (CAS 2157-01-9)
Vmax (nM/min/mg) and Km (µM) from rat-liver microsomes (100 µg/ml) determinations; CL = clearance as % removed from liver blood flow, T50% = Body elimination time (min) for 50% parent ester, Cmax = maximum concentration (mg/L) of MAA in blood, Tmax = time (min) to peak MAA concentration in blood from model predictions.
GSH conjugation, the second potential pathway, has only been observed with small alkyl methacrylates (methyl methacrylate/MMA, ethyl methacrylate/EMA) but was no longer measurable with butyl methacrylate. Moreover, GSH conjugation was only detectable with MMA and EMA at high concentrations which are only achievable under laboratory conditions (Elovaara et al., 1983, Mc Carthy et al., 1994).
Distribution
As the expected bioavailability is very low that means neither GI- and respiratory absorption nor dermal absorption to a more than minimal extent are expected and complete metabolism is predicted, only a very low amount of the substance comes into consideration for distribution in blood or plasma and accumulation in organs and tissues. In theory the lipophilic molecule is likely to distribute into cells and then the intracellular concentration may be higher than extracellular concentration particular in fatty tissues, but this is of secondary importance as the bioavailability of the substance is very low.
Accumulation
In principle, C 17 Methacrylate accumulation in adipose tissue could be expected as the calculated log Pow is 9.1, but before that it is expected to be completely metabolized due to rapid cleavage by esterases as described above.
Excretion
As absorption is very low respectively not expected and complete metabolism is very fast, excretion of the parent compound is not to be expected.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.